» Articles » PMID: 33426346

Oral L-glutamine Rescues Fructose-induced Poor Fetal Outcome by Preventing Placental Triglyceride and Uric Acid Accumulation in Wistar Rats

Overview
Journal Heliyon
Specialty Social Sciences
Date 2021 Jan 11
PMID 33426346
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Metabolic adaptation of pregnant mothers is crucial for placental development and fetal growth/survival. However, evidence exists that indiscriminate consumption of fructose-enriched drink (FED) during pregnancy disrupts maternal-fetal metabolic tolerance with attendant adverse fetal outcomes. Glutamine supplementation (GLN) has been shown to exert a modulatory effect in metabolic disorders. Nevertheless, the effects of GLN on FED-induced poor fetal outcome, and in particular the impacts on placental uric acid/lipid accumulation are unknown. The present study was conducted to test the hypothesis that oral GLN improves fetal outcome by attenuating placental lipid accumulation and uric acid synthesis in pregnant rats exposed to FED.

Materials And Methods: Pregnant Wistar rats (160-180 g) were randomly allotted to control, GLN, FED and FED + GLN groups (6 rats/group). The groups received vehicle by oral gavage, glutamine (1 g/kg) by oral gavage, fructose (10%; w/v) and fructose + glutamine, respectively, through gestation.

Results: Data showed that FED during pregnancy caused placental inefficiency, reduced fetal growth, and caused insulin resistance with correspondent increase in fasting blood glucose and plasma insulin. FED also resulted in an increased placental triglyceride, total cholesterol and uric acid synthesis by activating adenosine deaminase and xanthine oxidase activities. Moreover, FED during pregnancy led to increased lipid peroxidation, lactate production with correspondent decreased adenosine and glucose-6-phosphate dehydrogenase-dependent antioxidant defense. These alterations were abrogated by GLN supplementation.

Conclusion: These findings implicate that high FED intake during pregnancy causes poor fetal outcome via defective placental uric acid/triglyceride-dependent mechanism. The findings also suggest that oral GLN improves fetal outcome by ameliorating placental defects through suppression of uric acid/triglyceride accumulation.

Citing Articles

Pregnancy Is Enough to Provoke Deleterious Effects in Descendants of Fructose-Fed Mothers and Their Fetuses.

Fauste E, Panadero M, Donis C, Otero P, Bocos C Nutrients. 2021; 13(10).

PMID: 34684668 PMC: 8539712. DOI: 10.3390/nu13103667.


Maternal Fructose Diet-Induced Developmental Programming.

Thompson M, DeBosch B Nutrients. 2021; 13(9).

PMID: 34579155 PMC: 8467222. DOI: 10.3390/nu13093278.

References
1.
Costa A, Real J, Antunes C, Cruz-Morais J . A new approach for determination of Na,K-ATPase activity: application to intact pancreatic β-cells. In Vitro Cell Dev Biol Anim. 2009; 46(1):7-10. DOI: 10.1007/s11626-009-9243-0. View

2.
Wu G, Morris Jr S . Arginine metabolism: nitric oxide and beyond. Biochem J. 1998; 336 ( Pt 1):1-17. PMC: 1219836. DOI: 10.1042/bj3360001. View

3.
Li J, Leng J, Li W, Zhang C, Feng L, Wang P . Roles of insulin resistance and beta cell dysfunction in macrosomia among Chinese women with gestational diabetes mellitus. Prim Care Diabetes. 2018; 12(6):565-573. PMC: 6778964. DOI: 10.1016/j.pcd.2018.07.010. View

4.
Roberts C . IFPA Award in Placentology Lecture: Complicated interactions between genes and the environment in placentation, pregnancy outcome and long term health. Placenta. 2010; 31 Suppl:S47-53. DOI: 10.1016/j.placenta.2010.01.001. View

5.
Pardo F, Silva L, Saez T, Salsoso R, Gutierrez J, Sanhueza C . Human supraphysiological gestational weight gain and fetoplacental vascular dysfunction. Int J Obes (Lond). 2015; 39(8):1264-73. DOI: 10.1038/ijo.2015.57. View